Core Insights - Phreesia Inc. is a healthcare technology company focused on patient intake management solutions, aiming to enhance efficiency and patient experience in a competitive landscape [1] Financial Performance - On December 8, 2025, Phreesia reported earnings per share (EPS) of $0.07, which was below the estimated $0.24, indicating profitability challenges [2][6] - The company generated revenue of approximately $120.3 million, missing the estimated $132.5 million, suggesting difficulties in achieving sales targets [3][6] - Analysts had anticipated earnings of 2 cents per share on revenue of $120.05 million, indicating that actual revenue was slightly above these expectations but still below broader market estimates [3] Financial Ratios - The price-to-sales ratio is about 2.60, suggesting investors are willing to pay $2.60 for every dollar of sales [4] - The enterprise value to sales ratio is approximately 2.38, indicating the company's valuation relative to its revenue [4] - Phreesia has a low debt-to-equity ratio of about 0.01, suggesting minimal reliance on debt financing [5] - The current ratio of approximately 2.44 indicates a strong ability to cover short-term liabilities with short-term assets, reflecting solid liquidity [5]